https://www.selleckchem.com/pr....oducts/larotrectinib
Background Vulnerable patients from marginalized groups (e.g., people with disabilities, people experiencing homelessness, black and minority ethnic communities) experience higher rates of ill-health, inequitable access to healthcare and low engagement with screening services. Addressing these disparities and ensuring healthcare provision is impartial and fair is a priority for the United Kingdom (UK) healthcare system. Aim Using Levesque's access conceptual framework, this study explored the views of patients from marginalized gr
Like
Comment
Share
